Incorporating New IO Therapies - Managing Patient Side Effects

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...

10 Okt 201842min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Okt 201856min

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Okt 201829min

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a serie...

28 Sep 201851min

Take Home Messages from AUA2018 Infertility / Andrology Lawrence Jenkins, MD, MBA The Ohio State University Sexual Dysfunction Nelson Bennett, Jr., MD, FACS Northwestern University Feinberg School o...

26 Sep 201819min

Take home messages from AUA2018 Endourology/Stones: Zeph Okeke, MD Infection/Inflammation: O. Lenaine Westney, MD, FPMRS

20 Sep 201824min

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series...

12 Sep 201832min

In a webinar on Feb. 26, moderator Seth Cohen, MD, and panelists Gina Badaloto, MD, Moben Mirza, MD, Jessica Kreshover, MD, and Taylor Kohn (MS4) provide an overview on the application cycle to the Ur...

6 Sep 20181h 29min